BACM
PFE icon

Blue Arrow Capital Management’s Pfizer PFE Stock Holding History

Blue Arrow Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-139,948
Closed -$4.62M – 173
2015
Q1 		$4.62M Buy
139,948
+68,541
+96% +$2.18M 0.45% 67
2014
Q4 		$2.11M Buy
+71,407
New +$2.05M 0.24% 102

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Blue Arrow Capital Management's PFE Position: Q2 2015 in Review

Blue Arrow Capital Management sold out of Pfizer (PFE) in Q2 2015, closing a stake of 139,948 shares — an estimated $4.62M sold.

Blue Arrow Capital Management first reported a position in PFE in Q4 2014 and held it in 2 quarters. The position peaked at $4.62M in Q1 2015. 1,888 funds tracked by Wall St. Rank hold PFE as of Q2 2015.

  • Blue Arrow Capital Management reported no remaining Pfizer position as of Q2 2015 after selling out during the quarter.
  • Blue Arrow Capital Management sold 139,948 Pfizer shares in Q2 2015, an estimated $4.62M.
  • Blue Arrow Capital Management first reported a position in Pfizer in Q4 2014 and held it in 2 quarters.
  • Blue Arrow Capital Management's Pfizer position peaked at $4.62M in Q1 2015.
  • 1,888 funds tracked by Wall St. Rank held Pfizer as of Q2 2015.

Based on Blue Arrow Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.